Asprosin-A Fasting-Induced, Glucogenic, and Orexigenic Adipokine as a New Promising Player. Will It Be a New Factor in the Treatment of Obesity, Diabetes, or Infertility? A Review of the Literature
- PMID: 33673009
- PMCID: PMC7918151
- DOI: 10.3390/nu13020620
Asprosin-A Fasting-Induced, Glucogenic, and Orexigenic Adipokine as a New Promising Player. Will It Be a New Factor in the Treatment of Obesity, Diabetes, or Infertility? A Review of the Literature
Abstract
Asprosin is a recently discovered protein released during fasting conditions mainly by adipocytes from white adipose tissue. As a glucogenic peptide, it stimulates the release of glucose from hepatic cells by binding to the OLFR734 receptor and leading to the activation of the G protein-cAMP-PKA pathway. As it crosses the blood-brain barrier, it also acts as an orexigenic peptide that stimulates food intake through activation of AgRP neurons in the hypothalamus; thus, asprosin participates in maintaining the body's energy homeostasis. Moreover, studies have shown that asprosin levels are pathologically elevated in obesity and related diseases. However, the administration of anti-asprosin antibodies can both normalize its concentration and reduce food intake in obese mice, which makes it an interesting factor to combat obesity and related diseases. Current research also draws attention to the relationship between asprosin and fertility, especially in men. Asprosin improves age- and obesity-related decrease in fertility potential by improving sperm motility. It should also be mentioned that plasma asprosin levels can be differentially modulated by physical activity; intense anaerobic exercise increases asprosin level, while aerobic exercise decreases it. However, further research is necessary to confirm the exact mechanisms of asprosin activity and its potential as a therapeutic target.
Keywords: PCOS; appetite; asprosin; exercise; fertility; insulin resistance; obesity.
Conflict of interest statement
The author declares no conflict of interest.
Figures
Similar articles
-
Energy Regulation Mechanism and Therapeutic Potential of Asprosin.Diabetes. 2020 Apr;69(4):559-566. doi: 10.2337/dbi19-0009. Diabetes. 2020. PMID: 32198197 Free PMC article. Review.
-
Asprosin, a novel pleiotropic adipokine implicated in fasting and obesity-related cardio-metabolic disease: Comprehensive review of preclinical and clinical evidence.Cytokine Growth Factor Rev. 2021 Aug;60:120-132. doi: 10.1016/j.cytogfr.2021.05.002. Epub 2021 May 28. Cytokine Growth Factor Rev. 2021. PMID: 34108103 Review.
-
Protein tyrosine phosphatase receptor δ serves as the orexigenic asprosin receptor.Cell Metab. 2022 Apr 5;34(4):549-563.e8. doi: 10.1016/j.cmet.2022.02.012. Epub 2022 Mar 16. Cell Metab. 2022. PMID: 35298903 Free PMC article.
-
Asprosin is a centrally acting orexigenic hormone.Nat Med. 2017 Dec;23(12):1444-1453. doi: 10.1038/nm.4432. Epub 2017 Nov 6. Nat Med. 2017. PMID: 29106398 Free PMC article.
-
Asprosin in health and disease, a new glucose sensor with central and peripheral metabolic effects.Front Endocrinol (Lausanne). 2023 Jan 5;13:1101091. doi: 10.3389/fendo.2022.1101091. eCollection 2022. Front Endocrinol (Lausanne). 2023. PMID: 36686442 Free PMC article. Review.
Cited by
-
Developmental and hormonal regulation of FBN1 and OR4M1 mRNA in bovine granulosa cells.Domest Anim Endocrinol. 2023 Jul-Oct;84-85:106791. doi: 10.1016/j.domaniend.2023.106791. Epub 2023 Apr 25. Domest Anim Endocrinol. 2023. PMID: 37167929 Free PMC article.
-
Obesity, White Adipose Tissue, and Adipokines Signaling in Male Reproduction.Mol Nutr Food Res. 2025 May;69(10):e70054. doi: 10.1002/mnfr.70054. Epub 2025 Apr 8. Mol Nutr Food Res. 2025. PMID: 40195898 Free PMC article. Review.
-
Low Serum Asprosin Levels in Fibromyalgia Syndrome: Insights from a Cross-Sectional Study.Medicina (Kaunas). 2025 Feb 26;61(3):410. doi: 10.3390/medicina61030410. Medicina (Kaunas). 2025. PMID: 40142221 Free PMC article.
-
Asprosin Exacerbates Endothelium Inflammation Induced by Hyperlipidemia Through Activating IKKβ-NF-κBp65 Pathway.Inflammation. 2023 Apr;46(2):623-638. doi: 10.1007/s10753-022-01761-7. Epub 2022 Nov 19. Inflammation. 2023. PMID: 36401667
-
The correlation between serum asprosin and left ventricular diastolic dysfunction in elderly patients with type 2 diabetes mellitus in the community.J Diabetes Investig. 2024 May;15(5):608-613. doi: 10.1111/jdi.14162. Epub 2024 Feb 16. J Diabetes Investig. 2024. PMID: 38363189 Free PMC article.
References
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials